Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibit

Journal Article · · J. Med. Chem.
; ; ; ; ; ; ; ; ;

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; NIGMS; OTHER
OSTI ID:
1836685
Journal Information:
J. Med. Chem., Vol. 64, Issue (21)
Country of Publication:
United States
Language:
ENGLISH

References (34)

Basic local alignment search tool October 1990
Cooperative binding of two acetylation marks on a histone tail by a single bromodomain October 2009
Affinity Map of Bromodomain Protein 4 (BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1 March 2014
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition June 2014
Domain-selective targeting of BET proteins in cancer and immunological diseases August 2020
Discovery and characterization of bromodomain 2–specific inhibitors of BRDT February 2021
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer January 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation March 2020
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology March 2014
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors March 2014
Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics March 2017
Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity February 2019
Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) Inhibitors August 2018
Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset October 2015
ERK5 kinase activity is dispensable for cellular immune response and proliferation September 2016
Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains August 2018
Identification of novel, potent and selective inhibitors of Polo-like kinase 1 January 2012
Accurate Prediction of the Relative Potencies of Members of a Series of Kinase Inhibitors Using Molecular Docking and MM-GBSA Scoring August 2006
MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement December 2012
tert -Butylsulfonyl (Bus), a New Protecting Group for Amines November 1997
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4 September 2019
Discovery of a hidden transient state in all bromodomain families January 2021
Targeting epigenetic reader domains by chemical biology August 2020
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development December 2020
Plasticity in binding confers selectivity in ligand-induced protein degradation June 2018
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands April 2017
Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof February 2021
Rapid measurement of binding constants and heats of binding using a new titration calorimeter May 1989
Protein-binding assays in biological liquids using microscale thermophoresis October 2010
Integration, scaling, space-group assignment and post-refinement January 2010
DIALS : implementation and evaluation of a new integration package February 2018
How good are my data and what is the resolution? June 2013
phenix.model_vs_data : a high-level tool for the calculation of crystallographic model and data statistics May 2010
Features and development of Coot March 2010

Similar Records

Related Subjects